serine has been researched along with Tremor in 5 studies
Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.
Tremor: Cyclical movement of a body part that can represent either a physiologic process or a manifestation of disease. Intention or action tremor, a common manifestation of CEREBELLAR DISEASES, is aggravated by movement. In contrast, resting tremor is maximal when there is no attempt at voluntary movement, and occurs as a relatively frequent manifestation of PARKINSON DISEASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Effect of 3, 4-dihydroxyphenylserine (DOPS), a norepinephrine precurosr, on harmaline tremor was investigated in mice to elucidate the role of norepinephrine in the genesis of tremor." | 7.65 | [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor]. ( Ikeda, Y; Inagaki, C; Ishikawa, M; Tanaka, C; Yamazaki, M, 1976) |
| "Effect of 3, 4-dihydroxyphenylserine (DOPS), a norepinephrine precurosr, on harmaline tremor was investigated in mice to elucidate the role of norepinephrine in the genesis of tremor." | 3.65 | [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor]. ( Ikeda, Y; Inagaki, C; Ishikawa, M; Tanaka, C; Yamazaki, M, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, S | 1 |
| Maeda, Y | 1 |
| Ohmori, H | 1 |
| Uchida, Y | 1 |
| Hirano, T | 1 |
| Yonemura, K | 1 |
| Uyama, E | 1 |
| Uchino, M | 1 |
| Kondo, T | 1 |
| Yamazaki, M | 1 |
| Ikeda, Y | 1 |
| Ishikawa, M | 1 |
| Inagaki, C | 1 |
| Tanaka, C | 1 |
| Wajsbort, J | 1 |
| Hemli, JA | 1 |
| Alfandary, I | 1 |
| Yahel, M | 1 |
| Siegfried, J | 1 |
| Gründig, E | 1 |
| Gerstenbrand, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of Routine Use of Critical View of Safety in Laparoscopic Cholecystectomy, Prospective Cohort Study[NCT03696823] | 50 participants (Anticipated) | Interventional | 2018-10-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 other studies available for serine and Tremor
| Article | Year |
|---|---|
Pantothenate kinase-associated neurodegeneration initially presenting as postural tremor alone in a Japanese family with homozygous N245S substitutions in the pantothenate kinase gene.
Topics: Acanthocytes; Adult; Anticonvulsants; Asian People; Asparagine; Basal Ganglia; Brain Mapping; Clonaz | 2004 |
[D,L-threo-3,4-dihydroxyphenylserine (D,L-threo-DOPS) treatment on the patients with Parkinson's disease or pure akinesia].
Topics: Aged; Droxidopa; Female; Gait; Humans; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parki | 1984 |
[Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor].
Topics: Alkaloids; Animals; Brain Chemistry; Droxidopa; Drug Synergism; Harmaline; Isomerism; Locomotion; Ma | 1976 |
[Clinical studies on the treatment of parkinsonism with the L-dopa and decarboxylase inhibitor Ro-4-4602 association].
Topics: Aged; Benzyl Compounds; Carboxy-Lyases; Dihydroxyphenylalanine; Female; Humans; Hydrazines; Male; Mi | 1971 |
[Correlation between Parkinsonism symptoms and a disorder in the amino acid metabolism in CNS].
Topics: Amino Acids; Animals; Brain Injuries; Central Nervous System Diseases; Cerebrospinal Fluid; Cysteine | 1970 |